• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乙酰肝素酶的结构表征揭示了对底物识别的见解。

Structural characterization of human heparanase reveals insights into substrate recognition.

作者信息

Wu Liang, Viola Cristina M, Brzozowski Andrzej M, Davies Gideon J

机构信息

Department of Chemistry, University of York, York, UK.

出版信息

Nat Struct Mol Biol. 2015 Dec;22(12):1016-22. doi: 10.1038/nsmb.3136. Epub 2015 Nov 16.

DOI:10.1038/nsmb.3136
PMID:26575439
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5008439/
Abstract

Heparan sulfate (HS) is a glycosaminoglycan that forms a key component of the extracellular matrix (ECM). Breakdown of HS is carried out by heparanase (HPSE), an endo-β-glucuronidase of the glycoside hydrolase 79 (GH79) family. Overexpression of HPSE results in breakdown of extracellular HS and release of stored growth factors and hence is strongly linked to cancer metastasis. Here we present crystal structures of human HPSE at 1.6-Å to 1.9-Å resolution that reveal how an endo-acting binding cleft is exposed by proteolytic activation of latent proHPSE. We used oligosaccharide complexes to map the substrate-binding and sulfate-recognition motifs. These data shed light on the structure and interactions of a key enzyme involved in ECM maintenance and provide a starting point for the design of HPSE inhibitors for use as biochemical tools and anticancer therapeutics.

摘要

硫酸乙酰肝素(HS)是一种糖胺聚糖,构成细胞外基质(ECM)的关键成分。HS的降解由乙酰肝素酶(HPSE)完成,它是糖苷水解酶79(GH79)家族的一种内切β-葡萄糖醛酸酶。HPSE的过表达导致细胞外HS的降解以及储存的生长因子的释放,因此与癌症转移密切相关。在此,我们展示了分辨率为1.6-Å至1.9-Å的人HPSE晶体结构,揭示了潜在的前体HPSE通过蛋白水解激活而暴露的内切作用结合裂隙。我们使用寡糖复合物来绘制底物结合和硫酸盐识别基序。这些数据阐明了参与ECM维持的关键酶的结构和相互作用,并为设计用作生化工具和抗癌治疗剂的HPSE抑制剂提供了起点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/5008439/2109316c84fe/emss-68390-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/5008439/a90f25f47ddf/emss-68390-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/5008439/cb11f5e86184/emss-68390-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/5008439/4c06c4e0bf6b/emss-68390-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/5008439/4e6cd75eda16/emss-68390-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/5008439/2109316c84fe/emss-68390-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/5008439/a90f25f47ddf/emss-68390-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/5008439/cb11f5e86184/emss-68390-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/5008439/4c06c4e0bf6b/emss-68390-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/5008439/4e6cd75eda16/emss-68390-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d089/5008439/2109316c84fe/emss-68390-f005.jpg

相似文献

1
Structural characterization of human heparanase reveals insights into substrate recognition.人乙酰肝素酶的结构表征揭示了对底物识别的见解。
Nat Struct Mol Biol. 2015 Dec;22(12):1016-22. doi: 10.1038/nsmb.3136. Epub 2015 Nov 16.
2
An Overview of the Structure, Mechanism and Specificity of Human Heparanase.人源乙酰肝素酶的结构、机制和特异性概述。
Adv Exp Med Biol. 2020;1221:139-167. doi: 10.1007/978-3-030-34521-1_5.
3
Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.乙酰肝素酶降解syndecan-1和基底膜聚糖硫酸乙酰肝素:对肿瘤细胞侵袭的功能影响
J Biol Chem. 2004 Feb 27;279(9):8047-55. doi: 10.1074/jbc.M304872200. Epub 2003 Nov 20.
4
Non-reducing end labeling of heparan sulfate via click chemistry and a high throughput ELISA assay for heparanase.通过点击化学对肝素进行非还原末端标记及用于肝素酶的高通量 ELISA 检测。
Glycobiology. 2017 Jun 1;27(6):518-524. doi: 10.1093/glycob/cww130.
5
Chemical toolbox to interrogate Heparanase-1 activity.用于检测 Heparanase-1 活性的化学工具包。
Curr Opin Chem Biol. 2024 Jun;80:102452. doi: 10.1016/j.cbpa.2024.102452. Epub 2024 Mar 30.
6
Structural insights into heparanase activity using a fluorogenic heparan sulfate disaccharide.使用荧光性肝素硫酸二糖研究肝素酶活性的结构见解。
Chem Commun (Camb). 2020 Nov 10;56(89):13780-13783. doi: 10.1039/d0cc05932c.
7
Molecular model of human heparanase with proposed binding mode of a heparan sulfate oligosaccharide and catalytic amino acids.人源乙酰肝素酶的分子模型及其与肝素硫酸寡糖和催化氨基酸的结合模式。
Biopolymers. 2012 Jan;97(1):21-34. doi: 10.1002/bip.21696. Epub 2011 Jul 21.
8
Heparanase: Historical Aspects and Future Perspectives.肝素酶:历史方面和未来展望。
Adv Exp Med Biol. 2020;1221:71-96. doi: 10.1007/978-3-030-34521-1_3.
9
Discovery and development of small-molecule heparanase inhibitors.小分子乙酰肝素酶抑制剂的发现与研制。
Bioorg Med Chem. 2023 Jul 15;90:117335. doi: 10.1016/j.bmc.2023.117335. Epub 2023 May 19.
10
Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.乙酰肝素酶和硫酸乙酰肝素相互作用蛋白的合成肽识别细胞表面和细胞外基质硫酸乙酰肝素上的共同位点。
J Biol Chem. 1997 Jun 20;272(25):15891-7. doi: 10.1074/jbc.272.25.15891.

引用本文的文献

1
Heparanase-Neutralizing Monoclonal Antibody (mAb A54) Attenuates Tumor Growth and Metastasis.硫酸乙酰肝素酶中和单克隆抗体(单克隆抗体A54)可抑制肿瘤生长和转移。
Cells. 2025 Sep 4;14(17):1379. doi: 10.3390/cells14171379.
2
The Pathophysiological Functions of Heparanases: From Evolution, Structural and Tissue-Specific Perspectives.乙酰肝素酶的病理生理功能:从进化、结构和组织特异性角度探讨
FASEB J. 2025 Sep 15;39(17):e70976. doi: 10.1096/fj.202501859R.
3
Heterodimeric protein entangling motifs: systematic discovery, feature analysis, and topology engineering.

本文引用的文献

1
Privateer: software for the conformational validation of carbohydrate structures.私掠者:用于碳水化合物结构构象验证的软件。
Nat Struct Mol Biol. 2015 Nov;22(11):833-4. doi: 10.1038/nsmb.3115.
2
Functional and structural characterization of a heparanase.肝素酶的功能和结构特征。
Nat Chem Biol. 2015 Dec;11(12):955-7. doi: 10.1038/nchembio.1956. Epub 2015 Nov 2.
3
Soluble heparan sulfate fragments generated by heparanase trigger the release of pro-inflammatory cytokines through TLR-4.由乙酰肝素酶产生的可溶性硫酸乙酰肝素片段通过Toll样受体4(TLR-4)触发促炎细胞因子的释放。
异二聚体蛋白缠结基序:系统发现、特征分析和拓扑工程
Chem Sci. 2025 Aug 8. doi: 10.1039/d5sc03953c.
4
Activity-based probes for dynamic characterisation of polysaccharide-degrading enzymes.用于多糖降解酶动态表征的基于活性的探针。
Biochem J. 2025 Jul 1;482(13):939-54. doi: 10.1042/BCJ20253060.
5
From Docking and Molecular Dynamics to Experimental Discovery: Exploring the Hydrophobic Landscapes of Heparanase to Design Potent Inhibitors.从对接和分子动力学到实验发现:探索乙酰肝素酶的疏水景观以设计强效抑制剂。
J Chem Inf Model. 2025 Jul 14;65(13):6899-6912. doi: 10.1021/acs.jcim.5c00371. Epub 2025 Jun 30.
6
Could Hydrophobicity of Sulfated Pseudo-Trisaccharides Derived from Repurposing Aminoglycoside Tobramycin Modulate the Enzymatic Activity of Heparanase?重新利用氨基糖苷类妥布霉素衍生的硫酸化假三糖的疏水性能否调节乙酰肝素酶的酶活性?
J Med Chem. 2025 Jun 26;68(12):12708-12732. doi: 10.1021/acs.jmedchem.5c00611. Epub 2025 Jun 11.
7
Design of Paromomycin and Neomycin as Sulfated and Hydrophobic Glycans to Target Heparanase-Driven Tumor Progression and Metastasis.将巴龙霉素和新霉素设计为硫酸化和疏水性聚糖以靶向乙酰肝素酶驱动的肿瘤进展和转移。
J Med Chem. 2025 Jun 12;68(11):12058-12084. doi: 10.1021/acs.jmedchem.5c00937. Epub 2025 May 28.
8
Investigation into the binding domains of platelet factor 4 unlocks new avenues for the design and synthesis of selective sulfated pseudo-tetrasaccharide aminoglycoside ligands.对血小板因子4结合域的研究为选择性硫酸化假四糖氨基糖苷配体的设计与合成开辟了新途径。
Eur J Med Chem. 2025 Oct 5;295:117792. doi: 10.1016/j.ejmech.2025.117792. Epub 2025 May 21.
9
Design Principle of Heparanase Inhibitors: A Combined In Vitro and In Silico Study.乙酰肝素酶抑制剂的设计原理:一项体外与计算机模拟相结合的研究
ACS Med Chem Lett. 2024 May 23;15(7):1032-1040. doi: 10.1021/acsmedchemlett.3c00268. eCollection 2024 Jul 11.
10
The Uptake of Heparanase into Mast Cells Is Regulated by Its Enzymatic Activity to Degrade Heparan Sulfate.肝素酶摄取入肥大细胞受其降解肝素硫酸的酶活性调节。
Int J Mol Sci. 2024 Jun 6;25(11):6281. doi: 10.3390/ijms25116281.
PLoS One. 2014 Oct 8;9(10):e109596. doi: 10.1371/journal.pone.0109596. eCollection 2014.
4
Dissecting conformational contributions to glycosidase catalysis and inhibition.剖析构象对糖苷酶催化作用和抑制作用的贡献。
Curr Opin Struct Biol. 2014 Oct;28:1-13. doi: 10.1016/j.sbi.2014.06.003. Epub 2014 Jul 10.
5
1H NMR spectroscopic studies establish that heparanase is a retaining glycosidase.1H 核磁共振波谱研究表明肝素酶是一种保留糖苷酶。
Biochem Biophys Res Commun. 2014 Jan 3;443(1):185-8. doi: 10.1016/j.bbrc.2013.11.079. Epub 2013 Nov 26.
6
Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues.肝素酶抑制机制研究:肝素硫酸盐类似物 PG545 及其三种结构类似物的作用。
FEBS Open Bio. 2013 Aug 2;3:346-51. doi: 10.1016/j.fob.2013.07.007. eCollection 2013.
7
How good are my data and what is the resolution?我的数据质量如何,分辨率是多少?
Acta Crystallogr D Biol Crystallogr. 2013 Jul;69(Pt 7):1204-14. doi: 10.1107/S0907444913000061. Epub 2013 Jun 13.
8
Multi-faceted substrate specificity of heparanase.肝素酶的多方面底物特异性。
Matrix Biol. 2013 Jun 24;32(5):223-7. doi: 10.1016/j.matbio.2013.02.006. Epub 2013 Mar 13.
9
Antitumor efficacy of the heparanase inhibitor SST0001 alone and in combination with antiangiogenic agents in the treatment of human pediatric sarcoma models.肝素酶抑制剂 SST0001 单独及联合抗血管生成药物治疗人小儿肉瘤模型的抗肿瘤疗效。
Biochem Pharmacol. 2013 May 15;85(10):1424-32. doi: 10.1016/j.bcp.2013.02.023. Epub 2013 Mar 1.
10
Deciphering mode of action of heparanase using structurally defined oligosaccharides.解析肝素酶作用模式:使用结构明确的寡糖。
J Biol Chem. 2012 Oct 5;287(41):34836-43. doi: 10.1074/jbc.M112.390161. Epub 2012 Aug 14.